India-Sweden Healthcare Innovation Centre launch ‘Skill For Scale’ prog for nurses

Collaborates with AIIMS Jodhpur and AstraZeneca India

India-Sweden Healthcare Innovation Centre, a collaboration between the Swedish Trade Commissioner’s Office, AIIMS New Delhi and AIIMS Jodhpur, launched ‘Skill For Scale’, an e-learning initiative designed to equip nurses with hands-on practical knowledge and skills to practice the latest patient care for managing non-communicable diseases. The programme is certified by AIIMS Jodhpur and is endorsed by the Directorate General of Health Services (DGHS) will allow nurses from across the country to register for free, and learn at their own pace.

The programme content and modules are created by the team of experts from AIIMS Jodhpur and an advisory board with representation from AIIMS Delhi, ICMR, DGHS, Indian Nursing Council (INC) and AstraZeneca. These modules will equip nurses to provide standardised and quality counselling, care and support services to the people to prevent and manage Diabetes. Subsequently, the training will be extended to other areas of NCDs in the subsequent phases like hypertension, cardiovascular and oncology.

With a multi-phased approach, the Skill for Scale programme is aimed to upskill 5000 nurses across the country within this year by converting the current theoretical and practical modules into easy interactive e-learning techniques. Explaining the need for such as upskilling programme Dr Sanjeev Misra, Director, AIIMS Jodhpur said, “NCD disease burden is increasing significantly in India and is already accounting for more than 60 per cent of deaths in India. It is also estimated that one in four people have a risk of dying from an NCD before the age of 70. This burden of NCD is expected to increase further over the coming years but the number of doctors with specialisations available to treat these increasing numbers is limited making it critical to upskill the existing healthcare practitioners in managing non-communicable diseases. Through this initiative, we are trying to bridge the knowledge gap that exists at the point of care for patients. The curriculum of this programme is carefully designed to enable nurses to deliver specialized care, essential support services and standardised counselling for patients living with an increasing incidence of non-communicable diseases in India”.

The e-learning mobile compatible programme is pegged at two levels-basic and advanced and includes training of 20-24 hours to be completed at your own pace. The course can be completed in two months further to which each student will be awarded a completion certificate from AIIMS Jodhpur.

“Skill for Scale program is in line with our continuous efforts and commitments to address the growing burden of NCDs on our healthcare systems. At AstraZeneca, we stand by our global initiatives and industry collaborations, focusing on creating awareness and upskilling key stakeholders to make healthier choices. The government’s recognition of this programme will go a long way to deliver accurate health information and ensure safe essential health services. We will continue to focus on upskilling the health workforce and bring impactful solutions locally and globally,” said Dr Anil Kukreja, VP of Medical Affairs and Regulatory, AstraZeneca India

By the end of the training, nurses will be able to recognise risk factors, causes, pathophysiology, screening methods, diagnostic tests and management of diabetes. They will gain an understanding to initiating timely action for confirmatory diagnosis and appropriate treatment, make timely referrals of complicated cases, follow standard treatment protocols, counsel and interact on the importance of early screening of diabetes, educate the community on the adoption of a healthy lifestyle and assist them to overcome barriers, myths and misconceptions.

Explaining the importance of industry support for critical healthcare programs, Cecilia Oskarsson, Swedish Trade Commissioner to India said, “ISHIC was created to address the healthcare challenges in the country through key pillars – technology, protocol and process and capability building. We are deeply encouraged to see the support these programmes have garnered from the government, key industry organisations which is crucial to be able to implement such a program at a national level and encourage wider use to be able to deliver benefits to the end patient and create an impact on the burden of healthcare. We will continue to evolve these programmes to be able to bring about holistic benefit to patients in their journey of managing non-communicable diseases”.

The initiative will be implemented under the direction of an Advisory Committee led by Prof Suresh K Sharma, Professor & Principal, College of Nursing, AIIMS Jodhpur. The advisory committee consists of key dignitaries from AIIMS Delhi, AIIMS Jodhpur, Directorate General of Health Services (DGHS), Indian Council of Medical Research (ICMR), Indian Nursing Council (INC), AstraZeneca India, and Business Sweden. This committee will be responsible to outline and review of the entire schedule of interventions, governing the overall framework, planning and on-ground conduct of the initiative, continuous evaluation of the project and developing a model for possible replication across the country.